Improved Self-management for Patients on Ventricular Assist Device (VAD) (SELMA)
Improved Health Care for People With Chronic Heart Disease and Implanted Cardiac Support Through Curricular Self-management - Phase 1: Prevalence Study
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 13353
- German Heart Center
-
-
Baden-Württemberg
-
Freiburg, Baden-Württemberg, Germany, 79110
- University Heart Center Freiburg
-
-
North Rhine-Westphalia
-
Bad Oeynhausen, North Rhine-Westphalia, Germany, 32545
- Heart and Diabetes Center North Rhine-Westphalia
-
-
Sachsen
-
Leipzig, Sachsen, Germany, 04289
- Leipzig Heart Center
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Outpatient at the respective heart center
- Living in a home environment
- On device between 3 months and 3 years
- 18 years and older
- No contraindications (e.g. cognitive, language)
- Signed Informed Consent
Exclusion Criteria:
- In-patient stay
- Not living in a home environment (e.g. assisted living)
- On device less than 3 months or more than 3 years
- Underage
- Contraindications (e.g. cognitive, language)
- No signed Informed Consent
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
VAD Patients
Patients with implanted ventricular assist device in the outpatient setting
|
Questionnaire survey on self-management
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-management Skills
Time Frame: October 2019 till January 2020
|
As an assessment instrument a standardized PRO measure was chosen to identify self-management skills and needs.
|
October 2019 till January 2020
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health-related Quality of Life
Time Frame: October 2019 till January 2020
|
The experienced health-related quality of life of the participants measured with a selfassessment questionnaire (QoL-VAD, KCCQ).
|
October 2019 till January 2020
|
|
Social Support
Time Frame: October 2019 till January 2020
|
The experienced social support of the participants measured with a selfassessment questionnaire (F-SozU).
|
October 2019 till January 2020
|
|
Symptoms of Anxiety
Time Frame: October 2019 till January 2020
|
Symptoms of anxiety measured via screening tool (HADS).
|
October 2019 till January 2020
|
|
Symptoms of Depression
Time Frame: October 2019 till January 2020
|
Symptoms of depression measured via screening tool (HADS, PHQ-9).
|
October 2019 till January 2020
|
|
Symptoms of Posttraumatic Stress Disorder
Time Frame: October 2019 till January 2020
|
Symptoms of posttraumatic stress disorder measured via screening tool (PTSD-7).
|
October 2019 till January 2020
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Comorbidities
Time Frame: October 2019 till January 2020
|
Relevant comorbidities (e.g.
Diabetes, Hypertension, psychic comorbidities) will be taken from the medical record of the participants.
|
October 2019 till January 2020
|
|
VAD Type
Time Frame: October 2019 till January 2020
|
Information on implanted VAD type (HVAD, HMIII or other) will be taken from the medical record of the participants.
|
October 2019 till January 2020
|
|
New York Heart Association (NYHA) classification
Time Frame: October 2019 till January 2020
|
Information on New York Heart Association (NYHA) classification of the participants will be taken from their medical record.
|
October 2019 till January 2020
|
|
VAD-related complications
Time Frame: October 2019 till January 2020
|
Emerged VAD-related complications (e.g.
neurologic events, major bleeding events, infections) will be taken from the patients' medical record.
|
October 2019 till January 2020
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Investigators
Investigators
- Study Director: Christiane Kugler, Prof. Dr., University of Freiburg
- Principal Investigator: Christiane Kugler, Prof. Dr., University of Freiburg
Publications and helpful links
General Publications
- Kugler C, Spielmann H, Seemann M, Lauenroth V, Wacker R, Albert W, Spitz-Koeberich C, Semmig-Koenze S, von Cube M, Tigges-Limmer K. Self-management for patients on ventricular assist device support: a national, multicentre study: protocol for a 3-phase study. BMJ Open. 2021 May 5;11(5):e044374. doi: 10.1136/bmjopen-2020-044374.
- Spielmann H, Seemann M, Friedrich N, Tigges-Limmer K, Albert W, Semmig-Konze S, Spitz-Koberich C, Kugler C. Self-management with the therapeutic regimen in patients with ventricular assist device (VAD) support - a scoping review. Heart Lung. 2021 May-Jun;50(3):388-396. doi: 10.1016/j.hrtlng.2021.01.019. Epub 2021 Feb 20.
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 01VSF18012
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.